French

Acasti Pharma Inc.

  • English
  • About Us
    • Management
    • Board of Directors
    • Scientific Advisory Boards
  • Clinical Pipeline
    • GTX-104
    • GTX-102
    • GTX-101
  • Investor Relations
    • Overview
    • News / Events
    • Company Info
    • Financial Results
    • Stock Data
    • Regulatory Filings
    • Governance
  • Newsroom
  • Careers
  • Contact
  • French

Press Releases

Investor Relations

Investor Relations

  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Media
    • IR Calendar
    • Email Alerts
    • Grace Merger Conference Call
  • Company Info
    • Overview
    • Presentations
    • Contacts
    • FAQ
  • Financial Results
  • Stock Data
    • NASDAQ: ACST
    • TSXV: ACST
  • Regulatory Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Section 16 Filings
    • SEDAR
    • Tax Notifications
  • Governance
    • Management Team
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News / Events

  • Overview
  • Press Releases
  • Media
  • IR Calendar
  • Email Alerts
  • Grace Merger Conference Call

Acasti Pharma CEO to Present at Microcap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16th

May 12, 2022

Acasti Pharma to Present at the B. Riley Securities' 2022 Virtual Neuro & Ophthalmology Conference on April 28th

Apr 25, 2022

Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors

Mar 25, 2022

Acasti Pharma Announces Patents for GTX-104 in Europe, GTX-102 in the U.S. and GTX-101 in Japan

Mar 22, 2022

Acasti Pharma Celebrates Rare Disease Day

Feb 28, 2022

Acasti Pharma Provides Business Update for the Third Quarter of Fiscal 2022

Feb 14, 2022

Acasti Pharma Schedules Third Quarter Fiscal 2022 Business Update Conference Call

Feb 7, 2022

Acasti Pharma to Present at the H.C. Wainwright BioConnect 2022 Conference

Jan 3, 2022

Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104

Dec 2, 2021

Acasti Pharma CEO to Participate in the Benzinga All Access Event on December 2nd

Nov 24, 2021
RSS
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...22
Next
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
© 2022 Acasti Pharma Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap